CVS Health Corp (CVS)
67.78
-0.72
(-1.05%)
USD |
NYSE |
Apr 24, 16:00
67.79
+0.01
(+0.01%)
After-Hours: 20:00
CVS Health Enterprise Value: 136.53B for April 23, 2024
Enterprise Value Chart
Historical Enterprise Value Data
Date | Value |
---|---|
April 23, 2024 | 136.53B |
April 22, 2024 | 137.96B |
April 19, 2024 | 138.11B |
April 18, 2024 | 137.65B |
April 17, 2024 | 136.66B |
April 16, 2024 | 137.20B |
April 15, 2024 | 137.11B |
April 12, 2024 | 136.71B |
April 11, 2024 | 138.09B |
April 10, 2024 | 139.87B |
April 09, 2024 | 142.65B |
April 08, 2024 | 144.01B |
April 05, 2024 | 144.19B |
April 04, 2024 | 143.33B |
April 03, 2024 | 144.21B |
April 02, 2024 | 143.23B |
April 01, 2024 | 150.45B |
March 28, 2024 | 150.70B |
March 27, 2024 | 150.29B |
March 26, 2024 | 150.15B |
March 25, 2024 | 149.72B |
March 22, 2024 | 149.09B |
March 21, 2024 | 148.83B |
March 20, 2024 | 149.72B |
March 19, 2024 | 148.56B |
Date | Value |
---|---|
March 18, 2024 | 147.95B |
March 15, 2024 | 147.73B |
March 14, 2024 | 146.50B |
March 13, 2024 | 144.81B |
March 12, 2024 | 144.98B |
March 11, 2024 | 145.90B |
March 08, 2024 | 144.80B |
March 07, 2024 | 143.83B |
March 06, 2024 | 143.88B |
March 05, 2024 | 143.09B |
March 04, 2024 | 143.32B |
March 01, 2024 | 143.25B |
February 29, 2024 | 143.92B |
February 28, 2024 | 144.95B |
February 27, 2024 | 146.31B |
February 26, 2024 | 146.51B |
February 23, 2024 | 147.48B |
February 22, 2024 | 147.36B |
February 21, 2024 | 147.42B |
February 20, 2024 | 146.36B |
February 16, 2024 | 147.36B |
February 15, 2024 | 146.73B |
February 14, 2024 | 146.49B |
February 13, 2024 | 146.71B |
February 12, 2024 | 147.60B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
126.15B
Minimum
Jun 14 2023
189.42B
Maximum
Feb 08 2022
150.97B
Average
148.01B
Median
Enterprise Value Benchmarks
Humana Inc | 30.28B |
IQVIA Holdings Inc | 55.61B |
Walgreens Boots Alliance Inc | 26.26B |
SCWorx Corp | 2.462M |
AirSculpt Technologies Inc | 386.45M |
Enterprise Value Related Metrics
Net Income (Quarterly) | 2.046B |
Revenue (Quarterly) | 93.81B |
Total Expenses (Quarterly) | 90.44B |
EPS Diluted (Quarterly) | 1.58 |
Gross Profit Margin (Quarterly) | 14.79% |
Profit Margin (Quarterly) | 2.18% |
Earnings Yield | 9.53% |
Operating Earnings Yield | 16.69% |
Normalized Earnings Yield | 10.26 |